MPS_NOVA Twinning
Company

MPS_NOVA Twinning

Biotechnology Research Online Via Teams 126 employees
Employees
126

MPS_NOVA Twinning Overview

Headquarters
Online Via Teams
Industry
Biotechnology Research
Employees
126
Founded
2024
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About MPS_NOVA Twinning

MPS NOVA is an EU Horizon Twinning project led by the Instituto de Tecnologia Química e Biológica (ITQB NOVA) in collaboration with NOVA Medical School (NMS). The goal of the project is to establish a European Hub of Excellence in Microphysiological Systems (MPS), leveraging pluripotent stem cell technologies to enhance the research and innovation capacity of Universidade Nova de Lisboa (UNL). MPS_NOVA focuses on developing advanced methodologies to study chronic diseases and host-microbe interactions, utilizing cutting-edge human-relevant systems like organ-on-a-chip devices. MPS NOVA unites key expertise from partner institutions across Europe: UNL - extensive experience in biomedical research models. Universitätsklinikum Jena (UKJ, Germany) - pioneering research in MPS systems. Fondazione Human Technopole (FHT, Italy) - leading innovations in pluripotent stem cell technologies. Max Delbrück Center for Molecular Medicine (MDC, Germany) - advanced integrative metabolomics and proteomics tailored for MPS applications. Together, these partners are forging the future of disease modeling!

Compare Similar Companies to MPS_NOVA Twinning